Mary M. Vaughan
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 10%
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 3
- Drug Transport and Resistance Mechanisms 3
- Cell Biology top 10%
- Nutrition and Dietetics top 10%
- Fatty Acid Research and Health 2
- Immunology and Allergy top 10%
-
- Glycosylation and Glycoproteins Research 3
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Nanoplatforms for cancer theranostics 2
- Co-authors
- Youcef M. RustumKároly TóthHarry K. SlocumMargot M. IpJohn K. CowellNancy S. PeressJennifer D. BlackKathleen M. Darcy
- Cited by
- Cancer ResearchOncologyCell Biology
- Partner nations
- United StatesChinaCanada
In The Last Decade
Mary M. Vaughan
27 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 224
- Oncology 370
- Cell Biology 157
- Nutrition and Dietetics 121
- Immunology and Allergy 46
Countries citing papers authored by Mary M. Vaughan
This map shows the geographic impact of Mary M. Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Vaughan more than expected).
Fields of papers citing papers by Mary M. Vaughan
This network shows the impact of papers produced by Mary M. Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Vaughan. The network helps show where Mary M. Vaughan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary M. Vaughan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 57 | |
| 2 | 2010 | 16 | |
| 3 | 2010 | 60 | |
| 4 | 2010 | 63 | |
| 5 | 2010 | 9 | |
| 6 | 2009 | 21 | |
| 7 | 2009 | 6 | |
| 8 | 2008 | 75 | |
| 9 | 2007 | 55 | |
| 10 | 2007 | 103 | |
| 11 | 2006 | 12 | |
| 12 | 2005 | 78 | |
| 13 | 2004 | 4 | |
| 14 | Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. | 2002 | 64 |
| 15 | 2001 | 41 | |
| 16 | 2000 | 46 | |
| 17 | 1999 | 19 | |
| 18 | 1995 | 29 | |
| 19 | New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. | 1994 | 45 |
| 20 | 1990 | 12 |
About Mary M. Vaughan
Mary M. Vaughan is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 27 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Cells and Metastasis (4 papers), Glycosylation and Glycoproteins Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Fatty Acid Research and Health (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Cancer Research (224 citations), Oncology (370 citations) and Cell Biology (157 citations). Mary M. Vaughan has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Youcef M. Rustum, Károly Tóth, Harry K. Slocum, Margot M. Ip, John K. Cowell, Nancy S. Peress, Jennifer D. Black, Kathleen M. Darcy, David G. Hicks and Danilo Zangani. Their work appears in journals such as Cancer Research, Brain Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.